These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21358971)

  • 21. Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review.
    Vincent B
    Pharmacol Res; 2018 Aug; 134():223-237. PubMed ID: 29981776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-amyloid, neuronal death and Alzheimer's disease.
    Carter J; Lippa CF
    Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemether Activation of AMPK/GSK3
    Li S; Zhao X; Lazarovici P; Zheng W
    Oxid Med Cell Longev; 2019; 2019():1862437. PubMed ID: 31871541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice.
    Sun C; Qiu X; Wang Y; Liu J; Li Q; Jiang H; Li S; Song C
    Neurosci Lett; 2020 Sep; 735():135192. PubMed ID: 32619650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin.
    Spinedi E; Cardinali DP
    Neuroendocrinology; 2019; 108(4):354-364. PubMed ID: 30368508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease.
    Takuma K; Yan SS; Stern DM; Yamada K
    J Pharmacol Sci; 2005 Mar; 97(3):312-6. PubMed ID: 15750290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Domingues C; da Cruz E Silva OAB; Henriques AG
    Curr Alzheimer Res; 2017; 14(8):870-882. PubMed ID: 28317487
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease.
    Spuch C; Antequera D; Isabel Fernandez-Bachiller M; Isabel Rodríguez-Franco M; Carro E
    Neurotox Res; 2010 May; 17(4):421-31. PubMed ID: 19774434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
    J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells.
    Sutinen EM; Pirttilä T; Anderson G; Salminen A; Ojala JO
    J Neuroinflammation; 2012 Aug; 9():199. PubMed ID: 22898493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease.
    Mihardja M; Roy J; Wong KY; Aquili L; Heng BC; Chan YS; Fung ML; Lim LW
    Ann N Y Acad Sci; 2020 Oct; 1478(1):43-62. PubMed ID: 32700392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Do Recent Clinical Trials Teach Us About the Etiology of AD.
    Robakis NK
    Adv Exp Med Biol; 2020; 1195():167. PubMed ID: 32468473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin administration reverses the alteration of amyloid precursor protein-cleaving secretases expression in aged mouse hippocampus.
    Mukda S; Panmanee J; Boontem P; Govitrapong P
    Neurosci Lett; 2016 May; 621():39-46. PubMed ID: 27068758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
    Jeong S
    Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.